Medicine, Gastroenterology

• 

  People

  • Administrative Positions

    • Burbridge, Rebecca Ann, Director of Advanced Endoscopy
    • Burbridge, Rebecca Ann, Associate Director of Clinical Endoscopy
    • Dufault, Darin Lyn, Director of Third Space Endoscopy
    • Muir, Andrew Joseph, Chief, Division of Gastroenterology in the Department of Medicine

  • Professorships

    • Diehl, Anna Mae, Florence McAlister Distinguished Professor of Medicine

  • Primary Appointments

    • Barto, Amy Elizabeth, Associate Professor of Medicine
    • Berg, Carl, Professor of Medicine
    • Bohorquez, Diego V., Associate Professor in Medicine
    • Bozymski, Eugene Michael, Adjunct Professor in the Department of Medicine
    • Brady, Carla Wheaton, Associate Professor of Medicine
    • Branch, Malcolm Stanley, Professor of Medicine
    • Brindise, Elizabeth Marie, Medical Instructor in the Department of Medicine
    • Burbridge, Rebecca Ann, Associate Professor of Medicine
    • Cassis, Paul N., Clinical Associate in the Department of Medicine
    • Chachu, Karen Ama-Serwa, Assistant Professor of Medicine
    • Choi, Steven Sok, Associate Professor of Medicine
    • Clark, Paul James, Adjunct Associate in the Department of Medicine
    • Clarke, William Thomas, Assistant Professor of Medicine
    • Cohn, Jonathan Allen, Professor of Medicine
    • Crocker, Justin Adams, Assistant Professor of Medicine
    • Diehl, Anna Mae, Professor of Medicine
    • Dinani, Amreen, Associate Professor of Medicine
    • Du, Kuo, Assistant Professor in Medicine
    • Dufault, Darin Lyn, Assistant Professor of Medicine
    • Farooq, Ahmad, Adjunct Assistant Professor in the Department of Medicine
    • Feiler, Michael Justin, Assistant Professor of Medicine
    • Garbutt Jr., John Tener, Associate Professor Emeritus of Medicine
    • Garman, Katherine Schuver, Associate Professor of Medicine
    • Gellad, Ziad F., Associate Professor of Medicine
    • Geneczko Jr., John Theodore, Assistant Consulting Professor in the Department of Medicine
    • Ghassemi, Sahar, Assistant Professor of Medicine
    • Glissen Brown, Jeremy, Assistant Professor of Medicine
    • Haque, Mahfuzul, Professor of Medicine
    • Hogan, Daniel Edward, Medical Instructor in the Department of Medicine
    • Hunt, Christine Marie, Adjunct Professor in the Department of Medicine
    • Jawitz, Nicole Gong, Assistant Professor of Medicine
    • Johnson, Alyson McGhan, Assistant Professor of Medicine
    • Jowell, Paul Simon, Professor of Medicine
    • Kaelberer, Melanie Maya, Assistant Professor of Medicine
    • Kappus, Matthew Robert, Associate Professor of Medicine
    • Kieber-Emmons, AnnMarie, Assistant Professor of Medicine
    • King, Lindsay Yount, Assistant Professor of Medicine
    • Kothari, Darshan J, Associate Professor of Medicine
    • Lee, Richard Sommerville, Clinical Associate in the Department of Medicine
    • Leiman, David Asher, Associate Professor of Medicine
    • Liddle, Rodger Alan, Professor of Medicine
    • Lloyd, Benjamin Rembold, Assistant Professor of Medicine
    • Locklear, Cameron, Clinical Associate in the Department of Medicine
    • Long III, Thomas Theron, Associate Professor Emeritus of Medicine
    • Mah'moud, Mitchell Amuda, Consulting Professor in the Department of Medicine
    • McGreal, Nancy Marie, Associate Professor of Medicine
    • McHutchison, John George, Adjunct Professor in the Department of Medicine
    • McLeod, Michael E., Professor Emeritus of Medicine
    • Mook Jr., Robert Anthony, Assistant Professor in Medicine
    • Moore, Jill, Assistant Professor of Medicine
    • Moylan, Cynthia Ann, Associate Professor of Medicine
    • Muir, Andrew Joseph, Professor of Medicine
    • Obando, Jorge Valdemar, Associate Professor of Medicine
    • Oh, Seh Hoon, Assistant Professor in Medicine
    • Oloruntoba, Omobonike Oyindasola, Assistant Professor of Medicine
    • Onken, Jane Elizabeth, Associate Professor of Medicine
    • Patel, Ami Yogesh, Assistant Professor of Medicine
    • Patel, Amit, Associate Professor of Medicine
    • Patel, Keyur, Adjunct Associate Professor in the Department of Medicine
    • Patel, Yuval Adrash Dinesh, Assistant Professor of Medicine
    • Poleski, Martin Henry, Professor of Medicine
    • Ramchal, Talisha Dalini, Assistant Professor of Medicine
    • Rein, Matthew Gordon, Clinical Associate in the Department of Medicine
    • Roper, Jatin, Assistant Professor of Medicine
    • Russo, Steven M., Clinical Associate in the Department of Medicine
    • Segovia, Maria Cristina, Assistant Professor of Medicine
    • Shah, Dhvani, Assistant Professor of Medicine
    • Sharara, Ala Ihsan, Consulting Professor in the Department of Medicine
    • Shimpi, Rahul Arun, Assistant Professor of Medicine
    • Spaete, Joshua Paul, Assistant Professor of Medicine
    • Sullivan, Brian, Assistant Professor of Medicine
    • Suzuki, Ayako, Associate Professor of Medicine
    • Swain, Sandip Madhusudan, Assistant Professor in Medicine
    • Tahiliani, Varnita, Clinical Associate in the Department of Medicine
    • Teitelman-Grotegut, Melissa Gail, Associate Professor of Medicine
    • Tendler, David Andrew, Clinical Associate in the Department of Medicine
    • Thompson, Alexander, Adjunct Assistant Professor in the Department of Medicine
    • Toledo, Teodoro Keith, Clinical Associate in the Department of Medicine
    • Vance, Iris Lillian, Assistant Professor of Medicine
    • Veerappan, Annapoorani, Assistant Professor of Medicine
    • Wang, Jiangbo, Assistant Professor in Medicine
    • Wegermann, Kara, Medical Instructor in the Department of Medicine
    • Wild, Daniel Murray, Professor of Medicine
    • Wilder, Julius Middleton, Assistant Professor of Medicine
    • Wilson, Joanne A. Peebles, Professor of Medicine
    • Wolf, Andrew Ira, Assistant Professor of Medicine
    • Wood Jr., Richard Kevin, Associate Professor of Medicine
    • Zachariah, Robin, Assistant Professor of Medicine
    • Zhang, Cecelia, Assistant Professor of Medicine

  • Secondary Appointments

    • Bashir, Mustafa Shadi Rifaat, Professor in Medicine
    • Guy, Cynthia Dianne, Professor of Medicine
    • Rawls, John Franklin, Professor in Medicine
    • Thacker, Julie K. Marosky, Associate Professor in Medicine

  • Non-Faculty Positions

    • Earasi, Athidi, House Staff
    • Garbarino, Stephanie, House Staff
    • Gillespie, Jeremy, House Staff
    • Helzberg, James, House Staff
    • Henson, Jackie, House Staff
    • Layne, Sabrina, House Staff
    • Lee, Joshua, House Staff
    • Lorsch, Zach, House Staff
    • Noujaim, Michael, House Staff
    • Pioppo Phelan, Lauren, House Staff
    • Reddy, Alexander, House Staff
    • Wall, April, House Staff
    • Wawrzynski, Joseph, House Staff
    • Wong, Natalie, House Staff

  • Affiliate Positions

    • Lee, Tzu-Hao, Affiliate
• 

  Administers Grant

  • A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults with pre-cirrhotic Non-Alcoholic Steatohepatitis (NASH)
  • A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in Patients with Primary Biliary Cholangitis with Inadequate Response or Intolerance to Ursodeoxycholic A
  • A PHASE 1, SINGLE DOSE PK AND SAFETY STUDY WITH NI-03 FOLLOWED BY A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP DOSE-RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NI-03 COMPARED TO PLACEBO IN SUBJECTS WITH CHRONIC PANCREATIs
  • A PHASE 2A, DOUBLE-BLIND, PLACEBOCONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF IRL201104 IN ADULT PARTICIPANTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS (EOE)
  • A PHASE 3, MULTI-CENTER, MULTI-NATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS
  • A PHASE 3, MULTI-CENTER, MULTI-NATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INDUCTION AND MAINTENANCE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS
  • A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects with Eosinophilic Esophagitis
  • A Phase 2 open-label study in patients with recurrent Genotype 1 Hepatitis
  • A Phase 2, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study of the Efficacy, Safety, and Tolerability of NM-002 in Adult Patients with Short Bowel Syndrome
  • A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Subjects with Chronic HCV Infection and Child-Pugh-Turcotte Class Cirrhosis
  • A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir
  • A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of NGM282 Administered for 12 Weeks in Patients with Histologically Confirmed Nonalcoholic Steatohepatit
  • A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of NGM282, Administered for 12 Weeks in Patients with Primary Sclerosing Cholangitis (PSC)
  • A Phase 2, Randomized, Double-blind, Placebo-controlled Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Dose Levels of Belcesiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
  • A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Adult and Adolescent Patients with Active Eosinophilic Esophagitis
  • A Phase 2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-104 in Subjects Ages 18-75 with Primary Biliary Cholangitis Who Are Unresponsive to UDCA and/or OCA
  • A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease
  • A Phase 3 Open-Label Clinical Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection
  • A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and safety of Rebiotix RBX2660 (microbiota suspension) for the Prevention of Recurrent Clostridium difficile Infection
  • A Phase 3 Randomized Multicenter Study to Evaluate the Efficacy and Safety of Open-Label Dual Therapy with Oral Vonoprazan 20 mg or Double-Blind Triple Therapy with Oral Vonoprazan 20 mg Compared to Double-Blind Triple Therapy with Oral Lansoprazole
  • A Phase 3, Multicenter, Open-Label, Extension Study to Evaluate the Efficacy and Safety of AK002 in Patients That Were Previously Enrolled in AK002-016 or AK002-012 Studies and have Eosinophilic Gastritis and/or Eosinophilic Duodenitis
  • A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients with Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis Who Have an Inadequate R
  • A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studyto Evaluate the Efficacy and Safety of AK002 in Patients with Moderately to Severely Active Eosinophilic Duodenitis who have an Inadequate Response with, Lost Response to, or
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis
  • A Phase 3, Randomized, Double-Blind, Two-Phase, Multicenter Study toEvaluate the Efficacy and Safety of Vonoprazan 20 mg Compared to Lansoprazole 30 mg for Healing in Patients with Erosive Esophagitis and to Evaluate the Efficacy and Safety of Vonop
  • A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors
  • A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C Previously Treated with an NS5A Inhibitor + Sofosbuvir Therapy
  • A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)
  • A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Sclerosing Cholangitis (VISTAS)
  • A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Seamless, Adaptive, Safety, Dose-Finding, and Phase 3 Clinical Study of UX701 AAV-Mediated Gene Transfer for the Treatment of Wilson Disease
  • A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen with out Interferon for Chronic Hepatitis C Infection in Gilead Sponsored Trials.
  • A gut brain neural circuit relevant to mental illnesses
  • A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
  • A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
  • A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
  • A randomized, double-blind, dose-ranging, placebo-controlled, Phase 2a evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with primary sclerosing cholangitis (PSC) and suspected liver fibrosis (INTEGRIS-PSC)
  • A systemically deliverable, RNAi-based approach for alcoholic liver disease
  • A two-part, randomized, placebo controlled, double blind, multicenter, Phase 3 study to evaluate the efficacy and safety of linerixibat for the treatment of cholestatic pruritus in participants with primary biliary cholangitis (PBC).
  • ADVANCED CRT IMPLANT EDUCATIONAL PROGRAM
  • ADVANCED CRT IMPLANT EDUCATIONAL PROGRAM - MEDTRONIC - COURSE IS FOCUSED ON PROVIDING CLINICAL AND TECHNICAL EDUCATION OPPORTUNITIES TO gASTROENTEROLOGISTS THAT CURRENTLY PERFORM eus PROCEDURES.
  • ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)
  • AbbVie M14-868 A Randomized, Open-label multicenter study to evaluate the efficacy, safety, and pharmacokinetics of co-administration of ABT-493 and ABT-530 with and without RBV in subjects with chronic hepatitis C virus (HCV) Genotype 2 or Genotype
  • Abbvie M13-596 A Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients with Chronic Hepatitis C Virus Genotype 1 - 6 Infection (MAGELLAN-2)
  • Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
  • Adult-to-Adult Living Donor Liver Transplantation Study Data Coordinating Center
  • Alphapump system in the treatment of refractory or recurrent ascites: a muticenter single arm within subject crossover design pivotal study (The POSEIDON Study)
  • An Observational Cohort Study of the Use of Avatrombopag in Patients with Thrombocytopenia Associated with Chronic Liver Disease Undergoing a Procedure
  • An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis ELEVATE UC OLE: An Open-Label Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
  • BMS AI443-102-0016 A Phase 3 Evaluation
  • BMS Muir, AI443-113
  • Bacteria sensory transduction from gut to brain to modulate behavior
  • Bioenergetics and Alcoholic Liver Disease Pathogenesis
  • CCK Cell Function
  • Characterizing Alcohol's Effects on Repair of Liver Injury
  • Cholesterol, Hedgehog Signaling & Fetal Alcohol Syndrome
  • Cologuard Impact in Clinical Practice: A Real-world Evidence Survey
  • CymaBay CB8025-31735
  • DAA-HCC - UT Southwestern
  • DOVA Education Program: Hepatology Update: Chronic Liver Disease Thrombocytopenia
  • Development of a Porcine Model of Esophageal Injury and Repair
  • Development of a multi-center research infrastructure for the Strength Training Intervention (STRIVE) for liver transplant candidates
  • Dopamine Receptor Regulation by GRKs in Drug Abuse
  • Duke Training Grant In Digestive Diseases And Nutrition
  • Duke Training Grant In Digestive Diseases And Nutrition
  • Duke Training Grant in Advanced Gastrointestinal Endoscopy
  • Duke Training Grant in Digestive Diseases and Nutrition
  • Effects of BCX4161 on the Pancreas
  • Efferent modulation of neuropod cells in the small intestine
  • Epigenetics and the Development of Nonalcoholic Fatty Liver Disease
  • Evaluation of Duodenoscope Contamination Following Implementation of Disposable Heads at Duke Hospital and Duke GI Endoscopy Clinics
  • Evidera PSC
  • Exact Sciences ALTUS
  • GS-US-342-1137
  • GS-US-428-4194
  • GS_US_342-1140
  • Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)
  • Genetic and Epigenetic Markers of Progressive Nonalcoholic Fatty Liver Disease
  • Gilead 337-1746 ¿A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies
  • Gilead 427-4024..A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Biliary Cholangitis Without Cirrhosis
  • Gilead 428-4025 - A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Sclerosing Cholangitis Without Cirrhosis
  • Gilead GS-342-1553 A randomized, open-label study to evaluate the efficacy and safety of Sofosbuvir/GS-5816 Fixed Dose Combination - Ribavirin for 24 weeks in Chronic HCV infected subjects who participated in a prior Gilead-sponsored HCV study.
  • Gilead HCV Heart and Lung - A Multicenter, open-label study of Harvoni® (sofosbuvir-ledipasvir fixed dose combination) in subjects infected with chronic hepatitis C and advanced heart failure or lung disease
  • Gilead Sponsored Research Agreement
  • Gut glutamatergic neurotransmission in sugar preference
  • Gut-Brain Neurocircuit Modulating Eating Behavior
  • HBV Clinical Research Network Site Application_Subcontract to UNC
  • HBV Clinical Research Network Site Application_Subcontract to UNC
  • HPN-100-022
  • Hedgehog Signaling and Adult Liver Regeneration
  • Hepatocellular Carcinoma, Epigenetics and Cadmium Exposure
  • Hippo-Yap Pathway, Ferroptosis of Hepatic Stellate Cells and Liver Fibrosis
  • IPA - Chieh-Chun HSU
  • IPA - Sandip M Swain
  • IPA - Steven R Vigna
  • Illuminating a gut-brain neural path for sensory signaling and pathogens
  • Immune surveillance in obesity-associated cancer
  • Impact of IMM-124E on Innate Immune and Fibrogenic Responses in Preclinical Mouse Model of NASH
  • Inhibition of CaMKK2 sensitizes rectal cancers to radiation therapy
  • Inhibition of Wnt/B-Catenin Signaling in Colorectal Cancer Therapy
  • Innovative Assays for Oncogenic Hedgehog Signaling
  • Integrated Role Of Cck On The Gastrointestinal Tract
  • Interferon-y for the treatment of chronic HCV infection
  • Interval Colonoscopy Screening for the Detection of Dysplasia in Inflammatory Bowel Disease
  • Inventiva NATiV3
  • Liver Derived Microparticles In Cirrhosis Pathogenesis
  • Liver Disease in Obesity
  • Low cost OCT probe for GI applications
  • Lumena PSC
  • MEDTRONIC ADVANCED CRT IMPLANT EDUCATIONAL PROGRAM
  • MK-3682 PN011 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regime of MK-5172 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT1, GT2 and GT4 Infection "C-CREST 1"
  • Madrigal 3196-18 A 52-Week, Phase 3 Open-Label Extension Study, with a Resmetirom (MGL-3196) in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension
  • Mechanisms Regulating Gastrointestinal Hormone Secretion
  • Mechanisms of Pancreatic Fibrosis
  • Mechanisms of mechanically-induced acute pancreatitis
  • Mechanosensing in Pancreatic Regeneration and Development
  • Medical Student Research Training Supplement
  • Medtronic SharkCore Needle - a prospective randomized study to examine the diagnostic accuracy of the Sharkcare versus the standard EUS needle in patients identified to have a hypoechoic solid tumor.
  • Merck MK-5172-017-02 A long-term follow-up study to evaluate the durability of Viro-Logic response and/or viral resistance patterns of subjects with Chronic Hepatitis C who have been previously treated with MK-5172 in a prior clinical trial.
  • Merck/MSD MK-5172-065-00
  • Metabolic Profiling to Identify Alcohol Biomarker Signature
  • Metabolic regulation of pancreatitis
  • NCDRC Pilot: Gut-Brain Neurotransmission for the Treatment of Type 2 Diabetes
  • NGM 14-0104
  • NIDDK NRSA T32 Diversity Administrative Supplement
  • Neural sensing of gut bacteria
  • Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
  • Novartis - AMBER - VAY736
  • Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients with EPI due to Chronic Pancreatitis (CP)
  • PREEMPT CRC: PREvention Employing a Multiomics Plasma-based Test for ColoRectal Cancer
  • PTSD-like phenotype of mice lacking GIT2
  • Pathogenesis of NASH Cirrhosis
  • Pathogenic Mechanisms of Pancreatitis
  • Pathophysiological Role of Glutaminolysis in Human NAFLD Progression
  • Pilot Grant for Gastrointestinal Biology Research
  • Pilot Study to Assess Changes in Immuneregulation with Phase of Chronic HBV Infection and Antiviral Therapy
  • Post-colonoscopy Risk Stratification Based on Germline and Somatic Genetic Factors
  • Predicting post-transplant mortality and global functional health based on pre-transplant functional status in liver transplantation
  • Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis
  • Quantifying Enteric Metabolism of Branched-chain Amino Acids in Relation to Other Dietary and Microbiota Nutrients
  • RESPONSE: A Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of Seladelpar in Patients with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
  • Rac1 Promotes Hepatic Stellate Accumulation/Activation in Liver Injury
  • Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)"
  • Rapid sugar sensing from gut to brain
  • Receptor Regulation of CCK Cell Function
  • Regulation of Gut Substance P Receptors
  • Regulation of Intestinal PYY cell function
  • Role of CAV3 Mutation in the Pathogenesis of Barrett's Esophagus
  • Role of Pancreatic Trypsin Inhibitor in Pancreatitis
  • Role of TLRs in human enteroendocrine cells
  • Role of enteroendocrine cells in the origin of Parkinson's pathology
  • Role of immune regulation in colorectal cancer chemotherapeutic response
  • Role of the Stroma in Fibrolamellar Hepatocellular Carcinoma
  • Same
  • Second Messenger Signaling In Cholecystokinin Cells
  • Second Messenger Signalling In Cholecystokinin Cells
  • Secretory Diarrhea--Cellular Mechanisms
  • Secretory Diarrhea: Cellular Mechanisms
  • Secretory Diarrhea: Cellular Mechanisms
  • Secretory Diarrhea: Cellular Mechanisms
  • Sensing Dietary Amino Acids from Gut to Brain
  • Smart-C - A phase IIIb open-label, multicentre, international randomised controlled trial of simplified treatment monitoring for 8 weeks glecapevir (300 gm)/pibrentasvis (120mg) in chronic HCV treatment naive patients without cirrhosis.
  • Specialized Consultation: Technical Expert in Predictive Toxicology
  • Steering Brain Behaviors Using Programmable Bacteria
  • Sub-Award Repository Samples -Noninvasive Assessment of Esophageal Varices in Patients with Unresectable Hepatocellular Carcinoma - Genentech
  • Submucosal esophageal structures as a progenitor niche for esophageal repair
  • Sulfasalazine in PSC
  • Surgical Approach to Experimental Pancreatitis
  • TAIWANJ JKB 121-001
  • TARGET-PBC A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis
  • TNF Alpha and Recovery from Alchoholic Liver Injury
  • TNF Alpha and Recovery from Alcoholic Liver Injury
  • TRX-2021-05 North Carolina Blue Cross Blue Shield Esophageal Therapeutics (NC BEST) Registry
  • TaiwanJ JKB 122AIH...A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis Patients Who Are Refractory or Intolerant to Current Therapies
  • Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
  • Targeting the WNT/beta-catenin pathway in triple negative breast cancer
  • Tasting gut bacteria
  • Technical Expert Services: Technical Expertise in Predictive Toxicology for Drug-induced liver injury (DILI)
  • The Cystic Fibrosis Gene and Chronic Pancreatitis
  • The Impact of Increasing Age on Waiting List and Post-Transplantation Outcomes for NAFLD Patients
  • The Impact of Race, Ethnicity, and Socioeconomic Status on Listing for Liver Transplant after Referral
  • The Molecular Basis Of Secretory
  • The Role of NAG-1 in Inflammatory Bowel Disease
  • The Southeastern Liver Health Cohort Study
  • The efferent synapse in neuropod cells
  • The molecular basis of secretory diarrhea
  • The neurotransmitter for calorie
  • The purpose of this study is to evaluate the use of passive, wirelessly observed therapy (WOT) using Proteus Discover¿ for maintaining HCV treatment adherence and achieving viral titer suppression in HCV-infected patients.
  • The role of Mtss1 in Hedgehog-mediated intestinal cancer stem cell function
  • The role of gastrin in esophageal submucosal gland acinar ductal metaplasia
  • The role of gut endocrine cells in Parkinson's Disease
  • Treatment of radiation proctitis in prostate cancer patients with a novel inducer of autophagy
  • Ultra-bright fluorescent nanoparticles for colorectal adenoma detection
  • Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression
  • Viral transduction of intestinal epithelium in the colon of mice mediated by sub-mucosal injection
  • Vitamin E Dosing Study (VEDS): A dose finding clinical trial of vitamin E for the treatment of adult NAFLD
  • Wnt signaling in obesity-associated colorectal cancer

Add data to my Website